It is suggested that radiomic features extracted from routine non-contrast MRI may help differentiate low-grade gliomas from encephalitis in diagnostically challenging cases; however, these preliminary findings warrant validation in larger multicenter cohorts before clinical implementation.
Abstract
Accurate differentiation between low-grade gliomas and encephalitis remains challenging due to overlapping MRI features. This study investigated whether MRI-based radiomics derived from routine non-contrast MRI could improve the differentiation of these entities in diagnostically challenging cases presenting in emergency settings. This retrospective single-center study included 41 patients with ambiguous MRI findings who underwent 3T MRI within 48 h of symptom onset. Radiomic features extracted from T2-FLAIR, DWI, and T1-TSE images, together with laboratory data available at presentation, were analyzed. Random Forest classifiers were developed using selected radiomic features, and model performance was evaluated using nested cross-validation, independent validation, receiver operating characteristic (ROC) analysis, and DeLong’s test. The cohort included 23 patients with histologically proven low-grade gliomas and 18 with confirmed encephalitis and was divided into training (
n
= 31) and validation (
n
= 10) sets. FLAIR-based models showed the best discriminatory performance, achieving an AUC of 0.82 (95% CI: 0.54–1.00) for both the radiomics-only and radiomics-clinical models outperforming T1-weighted (AUC 0.52 for radiomics-only and 0.60 for radiomics-clinical model) and DWI models (AUC 0.72 for both radiomics-only and radiomics-clinical approaches). The combined-sequence radiomics-clinical model achieved an AUC of 0.80 (95% CI: 0.41–1.00), with 100% sensitivity, 80% specificity, and 90% accuracy. Comparison of the ROC curves using DeLong’s test did not demonstrate statistically significant differences between the radiomics-only and radiomics-clinical models for any MRI sequence. This proof-of-concept study suggests that radiomic features extracted from routine non-contrast MRI may help differentiate low-grade gliomas from encephalitis in diagnostically challenging cases; however, these preliminary findings warrant validation in larger multicenter cohorts before clinical implementation.
Multiparametric MRI radiomics improves growth risk stratification beyond conventional imaging in incidental asymptomatic meningiomas, and a simplified scoring system may support personalized surveillance while reducing unnecessary interventions.
N. Mei, Yao Chen, B. Yin et al.· European Journal of Radiolog...· 0 citations
OBJECTIVE
To investigate the predictive value of radiomics features derived from diffusion kurtosis imaging and dynamic contrast-enhanced MRI for aggressive pathological characteristics of oral and oropharyngeal squamous cell carcinoma (SCC).
STUDY DESIGN
This prospective single-center study enrolled 157 patients wit...
MRI-based radiomics combined with ML algorithms demonstrates excellent performance in differentiating endometriomas from HOCs, and may hold clinical significance and, pending external validation, boost diagnostic confidence, decrease unnecessary surgeries, and aid in better patient management.
Armin Doostparast, Zahra Alami, S. Sadeghpour et al.· European Journal of Radiolog...· 0 citations
A radiomics-based multi-sequence MRI machine learning model may serve as a non-invasive adjunct for preoperative Ki-67 estimation in GBM, and the combined sequence approach outperformed single modalities, and SHAP analysis enhanced interpretability.
Juan Ma, Palidanmu Wumaier, Gulijianaiti Maiamaituxun et al.· Frontiers in Molecular Biosc...· 0 citations
Preliminary evidence supporting the utility of 7T MRSI for glioma subtype characterization and shows potential for the differentiation of GBM, AST, and ODG is provided and further validation in larger studies is suggested.
S. Huskić, P. Lazen, Thomas Roetzer-Pejrimovsky et al.· Cancer Imaging· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.